18F-FDG PET/CT for Monitoring Response of Merkel Cell Carcinoma to the Novel Programmed Cell Death Ligand 1 Inhibitor Avelumab
2018 ◽
Vol 43
(5)
◽
pp. e142-e144
◽
Naghmehossadat Eshghi
◽
Tamara F. Lundeen
◽
Lea MacKinnon
◽
Ryan Avery
◽
Phillip H. Kuo